Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
6.42
+0.12 (1.90%)
At close: Jul 31, 2026, 4:00 PM EDT
6.45
+0.03 (0.47%)
After-hours: Jul 31, 2026, 4:54 PM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 28 employees as of December 31, 2025. The number of employees increased by 3 or 12.00% compared to the previous year.
Employees
28
Change (1Y)
3
Growth (1Y)
12.00%
Revenue / Employee
n/a
Profits / Employee
-$1,856,750
Market Cap
659.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 3 | 12.00% |
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| Neurogene | 131 |
| BridgeBio Oncology Therapeutics | 106 |
| AgomAb Therapeutics NV | 62 |
ACHV News
- 10 hours ago - Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Achieve Life Sciences added to Russell 2000 Index - TheFly
- 4 weeks ago - Achieve Life Sciences Joins Russell 2000® Index - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences resumed with a Strong Buy at Raymond James - TheFly
- 5 weeks ago - Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility - TheFly
- 5 weeks ago - US FDA declines to approve Achieve Life Sciences' smoking-cessation drug - Reuters
- 5 weeks ago - Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA - GlobeNewsWire